BrightSpring stockholders to sell 15 million shares in secondary offering

LOUISVILLE - BrightSpring Health Services, Inc. (NASDAQ:BTSG), a $6.1 billion market cap healthcare provider with annual revenue exceeding $12.5 billion, announced Monday that certain stockholders plan to offer 15 million shares of common stock in a secondary offering, with the company receiving none of the proceeds. According to InvestingPro, the company has emerged as a prominent player in the Healthcare Providers & Services industry.

The selling stockholders include an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of BrightSpring’s management team, according to a press release statement.

BrightSpring, a provider of home and community-based health services, has authorized the concurrent purchase of shares from the underwriter worth up to 10% of the shares sold or $50 million, whichever is less. The company will pay the same price per share that the underwriter pays to the selling stockholders, with the underwriter receiving no fees for shares repurchased by BrightSpring.

BofA Securities is serving as the sole book-running manager for the offering. The shares will be offered through various channels including the Nasdaq Global Market and over-the-counter market at prevailing market prices or negotiated prices.

The offering is being made under a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission on June 10, 2025, and became automatically effective upon filing.

The share repurchase is expected to close simultaneously with the offering, though the offering itself is not contingent on the completion of the repurchase.

In other recent news, BrightSpring Health Services reported strong financial results for the second quarter of 2025. The company achieved a 29% year-over-year increase in total revenue, reaching $3.1 billion. A significant contributor to this growth was the pharmacy solutions division. Additionally, BrightSpring Health saw a rise in adjusted earnings per share to $0.22. These results highlight the company’s robust performance during the quarter. Despite the positive financial outcomes, the stock experienced a slight decline in aftermarket trading. This development follows recent analysis from various firms, reflecting a complex market response to the earnings report. Investors and analysts will likely continue to monitor BrightSpring Health’s performance in the coming quarters.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.